7 ) and a (R)-3-hydroxy-12-methyltetradecanoic acid (HMT) residue, was isolated from the crude culture extract of Bacillus sp. SY27F, which was obtained from the Indian Ocean hydrothermal vent. Its planar structure was elucidated by spectroscopic analyses, including 1D and 2D NMR spectroscopy, mass spectrometry (MS), and secondary ion mass spectrometry (MS/MS), whereas its absolute configuration was determined by modified Marfey's analysis. Bacilohydrin A displayed significant cytotoxicities against DU-145, MCF-7 and HepG2 cancer cell lines with IC 50 values of 50.3-175.1 nM. Additionally, this is the first time to determine the absolute configuration of a D-aspartic acid residue in surfactin class.
Deep-sea hydrothermal vents are among the most extreme and dynamic environments on earth [1] . To adapt to such an environment, vent organisms have formed a unique defense mechanism and metabolic pathway indicating a potential discovery of new natural products [2] . In fact, bacteria form a relatively large portion of the known vent organism diversity [3] [4] . Bacillus, belonging to phylogenetically and phenogenetically heterogeneous groups of bacteria, can tolerate diversely extreme and dynamic conditions and produce versatile secondary metabolites including lipopeptides, polypeptides, macrolactones, fatty acids, polyketides, lipoamides, and isocoumarins [5] [6] [7] . Among these compounds, cyclic lipopeptides have received considerable attention for their effective biological activities such as antimicrobial, antiviral, anticancer and exceptional surfactant properties [8] [9] [10] [11] .
Cyclic lipopeptides (cLPs), belonging to three families of iturins, fengycins, and surfactins, are natural compounds produced by a variety of bacterial genera, such as Streptomyces, Pseudomonas, and Bacillus [12] [13] [14] . Their chemical structures generally possess a peptide backbone composed of seven or ten amino acids and a β-hydroxy or β-amino fatty acid to form a macrocyclic structure. The N-terminal end of the peptide backbone gives rise to one amide bond with the carboxylic group of the fatty acid, while the 3-hydroxy or 3-amino group of the fatty acid is involved in an ester or amide bond, respectively, with the C-terminal amino acid [15] .
As part of ongoing investigations into the chemical diversity and biological activity of marine microorganisms, a Bacillus sp. SY27F, attracted our attention because its crude EtOAc extract exhibited potential antitumor activity. Further isolation yielded a new cyclic lipopeptide: bacilohydrin A (Figure 1 ). The planar structure of bacilohydrin A was elucidated by NMR and mass spectrometric methods, and the absolute configuration was elucidated by modified Marfey's analysis. Biological evaluation of bacilohydrin A revealed significant cytotoxicities activity against HepG2, MCF-7 and DU-145 cancer cells and moderate to weak cytotoxicity against A549, HeLa and HT1080, but no antibacterial activity against E. coli, S. aureus and M. albican. Surfactins class with a D -aspartic acid residue has not been previously reported. The strain was isolated from a marine sediment sample collected from the deep-sea hydrothermal vent in the Indian Ocean and identified as Bacillus by 16s rRNA sequencing. The growth conditions of the strain for maximum metabolites production were optimized through culturing in combination of different salinity of water, pH, rotate speed and temperature before proceeding of large scale culture. The optimal salinity of water, pH, rotate speed and temperature were found to be 20 g/L, 7.6, 180 rpm and 50°C, respectively, for the maximum growth of the strain. The growth curve of strain was then measured following above conditions to determine the inoculation and fermentation time to be 12 h and 168 13 C data analysis indicated the lipopeptidic nature of bacilohydrin A. Analysis of the HSQC, HMBC, and 1 H− 1 H COSY spectra suggested that bacilohydrin A contained seven amino acid residues including an isoleucine (Ile), a glutamine (Gln), a valine (Val), an aspartic acids (Asp), and three leucines (Leu). The residual fragment was a long-chain fatty acid with 15 carbons, which was further confirmed from the acid hydrolysis of bacilohydrin A followed by LC-MS analysis (t R =0. Figure 3B and S5) showed a first loss of amino acid residues after the cleavage of the ester bond, which indicated the existence of a cyclic structure [16] . The fragment at 113 amu corresponds to either leucine or isoleucine, but according to the NMR data and the chemical degradation study must be iso-leucine. In particular, these peaks were indicative of the consecutive losses of Ile and Leu residues from the C- [17] [18] . Starting from the molecular ion peak at m/z 1057 ( Figure S6 and 3D) , the difference from the ion peak at m/z 813 (−244) was attributed to the loss of the dipeptide residue Ile-Leu-H 2 O. This confirmed that an Ile residue at the C-terminal end gives rise to the ester bond with the 3-hydroxyl group, affording the typical 25-membered lactone ring of the cyclopeptide skeleton. Figure 3D shows the set of fragment ions produced from bacilohydrin A after cleaving the cyclic structure by a double hydrogen transfer mechanism that confirmed the amino acid sequence found after a simple cleavage mechanism.
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The amino acid residues were identified as L -Ile, L -Leu, L -Val, D -Asp, L -Leu, L -Leu, L -Gln by modified Marfey's method [19] and LC-MS analysis ( Figure S14 ). This is the first time to report the absolute configuration of D-aspartic acid residue in surfactins class. After permethylation with ethereal diazomethane, the lipophilic fraction was shown to contain 3-methoxy-12-methyltetradecanoic acid, as identified by GC-MS and NMR. The absolute configuration In order to investigate the effects on biological properties of the surfactins class, bacilohydrin A was subjected to several preliminary tests including antimicrobial activity and cytotoxic property. Minimum inhibitory concentration of bacilohydrin A was evaluated against E. coli, S. aureus and M. albican following broth dilution assay [23] . Bacilohydrin A did not exhibit any antimicrobial activity against E. coli, S. aureus and M. albican. This unexpected lack of antimicrobial activity might be due to the insufficient overall positive charge contributed by their structure and functionality [24] . A detailed analysis of mechanism will help to answer these questions. The cytotoxicity of bacilohydrin A was evaluated against six human cancer cell lines (A549, HeLa, HT1080, HepG2, MCF-7, and DU-145) by CCK-8 assay according to the manufacturer's protocol [25] (Table 2) . Bacilohydrin A showed significant cytotoxicity against HepG2, MCF-7, and DU-145, with IC 50 values of 50.3-175.1 nM, and exhibit moderate to weak cytotoxicity against A549, HeLa and HT1080, with IC 50 values of 7.8-29.5 μM, respectively. For instance, halobacillin reported as a cLP inhibits the growth of human colon tumor cells (HCT-116) with an IC 50 of 0.98 μg/mL, but it showed none of the antibacterial activity exhibited by surfactin [26] . Other reports indicate that the anti-proliferative effects of cLPs on tumor cells is by inducing the apoptosis, which is related with the enzyme activities [27] [28] . Morphologic changes of cell including cell shrinkage, condensation and fragmentation of nuclei revealed that bacilohydrin A showed cytotoxicity against cancer cell lines by inducing apoptosis (Figure 4 and S16). It may be considered to be potential antitumor agents.
Experimental
General experimental procedures: Optical rotations were acquired on a Jasco P-1010 polarimeter with MeOH/CH 3 Cl as solvent in a 100 × 2 mm cell at room temperature. The UV spectrum was determined using Perkin Elmer double beam spectrophotometer Model 550S, attached to a Hitachi recorder Model 561, using 1 cm quartz cell. IR spectrum was determined using Nicolet AVATAR360 FT-IR spectrophotometer using KBr plates. GC-MS was conducted with an Agilent 6890N-5973 using Agilent HP-5 GC column (30m×0.25mm×0.25um). 1 H and 13 C NMR, DEPT-135, and 2D NMR spectra were recorded on an Avance-500 spectrometer (Bruker). Open column chromatography was performed using silica gel (250-400 mesh, Aladdin), ODS packing and Sephadex LH-20 (Beijing Greenherbs Science and Technology Development Co., Ltd.), respectively. Pre-coated silica gel GF254 plates (10-40 μm, Yantai Jiangyou Silica Gel Development Co., Ltd.) were used for TLC analyses, equipped with variable wavelength detector, was used for flash column chromatography. MS, MS/MS and MSE of UPLC-QTOF spectra were obtained with a Waters Xevo G2-XS QTOF using Waters ACQUITY UPLC®BEH C18 column (1.7 µm, 2.1×100 mm, 0.3 mL/min) in both ESI positive mode and ESI negative mode (sensitivity analyser mode, acquire MSE over the range 100-2000 Da, scan time 0.2 s, collision energy 6V, ramp collision energy 20-90 V). High-performance liquid chromatography (HPLC) was performed on a semi-preparative Waters e2695 separation module using Agilent semipreparative ZORBAX Eclipse XDB-C18 column (5 µm, 9.4 × 250 mm, 2 mL/min), equipped with a Waters UV/Vis detector and a Waters fraction collector Ⅲ.
Bacterial isolation and identification:
The strain was isolated from sediment in the Indian Ocean hydrothermal vent (25°19′13.66″ S, 70°02′25.47″ E, depth 2,430 m) and was maintained on 2216E agar plate. The species was identified as Bacillus on the base of its morphological characteristics and 16S rRNA sequence comparison by a National Center for Biotechnology Information Basic Local Alignment Search Tool search under accession number (MH591471). In a typical experiment, DNA extraction was performed using TaKaRa MiniBEST Bacteria Genomic DNA Extraction Kit Ver.3.0 provided by Bao-Biology Ltd. (Dalian, China) according to the manufacturer's protocol. The DNA regions were amplified using the popular universal bacterial primers 27F/1492R (Sangon Biotech). For a detailed description of the producer strain about the morphological characterization, see the Supporting Information (Fig. S1) .
Fermentation, extraction and isolation:
A well-grown culture of strain SY27F on 2216E agar plate was used to inoculate 100 mL of 2216E media in a 250 mL Erlenmeyer flask at 50°C with shaking at 180 rpm. After 18 h cultivation,10 mL of this primary culture was transferred into 1 L Erlenmeyer flasks with 500 mL of medium each. These cultures were incubated at 50°C and 180 rpm on rotary shakers for 7 days. The total volume of fermentation is 80 L. For extraction, the supernatant was separated from the mycelia using a Sorvall RC-6 Plus centrifuge (Thermo Fisher Scientific). The supernatant was extracted using EtOAc until EtOAc is colorless. The mycelia was extracted using MeOH and evaporated (50℃). The residue diluted in water and extracted with EtOAc. The organic phase was collected, dried over sodium sulfate and evaporated to dryness (50°C) to obtain a dark brown oil crude extract (2.0 g). The EtOAc extracts were concentrated and subjected to ODS chromatography eluted with MeOH/H 2 O in a gradient eluent Modified Marfey's analysis: Bacilohydrin A (ca. 2.0 mg) was dissolved with 1mL of 6 N HCl for 72 h at 110°C in a sealed tube. After cooling, the resulting solution was diluted with water, and the lipophilic products were extracted with chloroform. Both phases were evaporated under a stream of N 2 and analyzed separately. The aqueous part was reconstituted in 25 μL of H 2 O and was added 10 μL of 1 M sodium bicarbonate solution followed by 50 μL of a 1 mg/mL solution of L -FDAA (1-fluoro-2,4-dinitrophenyl-5-L-alanine amide) in acetone. The solution was maintained at 40°C for 1 h, at which time the reaction was neutralized by the addition of 5 μL of 2 N HCl. The reaction mixture was then evaporated under a stream of N 2 and resuspended in 200 μL of MeOH, and 1 μL of the solution was analyzed by LC-ESIMS using Waters ACQUITY UPLC®BEH C18 column (1.7 µm, 2.1 × 100 mm, 0.3 mL/min) and eluting with acetonitrile-0.01% formic acid and 0.05% ammonium hydroxide in water, using a 0% to 30% gradient over 20 min. Each standard amino acid (approximately 0.2 mg) was taken separately in 2 mL vials, followed by 50 μL of water, 20 μL of 1 M sodium bicarbonate solution, and 100 μL of a 1 mg/mL solution of L -FDAA (1-fluoro-2,4-dinitrophenyl-5-L-alanine amide) in acetone. The reaction mixture was heated at 40°C for 1 h and quenched with 10 μL of 2 N HCl. The resulting mixture was dried under a stream of N 2 and dissolved in 1 mL of MeOH. Each of the derivatized amino acid standards was then injected individually in LC-ESIMS following
